Letters to the Editor

concealment. The approach of dividing alternating subjects between one group and the other was not used in the study. D. Vasudevan, Manoj M. Naik1, Qayum I. Mukaddam1 The Brain Spine and Nerve Centre, Chennai, Tamil Nadu, 1 Medical Services, Abbott Healthcare Pvt. Limited, Mumbai, Maharashtra, India For correspondence: Dr. Manoj M. Naik, Abbott Healthcare Pvt. Limited,

‘D’ Mart Building, Opposite Wockhardt Hospital, Goregaon Mulund Link Road, Mulund (W), Mumbai - 400 080, Maharashtra, India. E-mail: manoj.naik@ abbott.in

References 1.

481

versus pregabalin monotherapy in improving pain and nerve conduction velocity in type 2 diabetes associated impaired peripheral neuropathic condition. [MAINTAIN]: Results of a pilot study. Ann Indian Acad Neurol 2014;17:19-24. 2. E 10 Choice of control group and related issues in clinical trials. Guidance for industry. U.S. Department of Health and Human Services Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER). May 2001. ICH. Available from: http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/ ucm073139.pdf [Last accessed on 2014 May 7]. Access this article online Quick Response Code:

Website: www.annalsofian.org

DOI: 10.4103/0972-2327.144048

Vasudevan D, Naik MM, Mukaddam OI. Efficacy and safety of methylcobalamin, alpha lipoic acid and pregabalin combination

Conducting randomized controlled trials in clinical settings of a pilot study Sir, This is regarding an article entitled, “Efficacy and safety of methylcobalamin, alpha lipoic acid, and pregabalin combination versus pregabalin monotherapy in improving pain and nerve conduction velocity in type 2 diabetesassociated impaired peripheral neuropathic condition. [MAINTAIN]: Results of a pilot study” published in Annals of Indian Academy of Neurology (Ann Indian Acad Neurol 2014; 17:19-24).[1] The authors need to be appreciated for their effort. The authors state that the study was an open, randomized, and controlled parallel group 12-week pilot study conducted at a single centre in Chennai, Tamil Nadu, India for which a total of 30 patients were screened. The authors further elaborate on the methodology adopted for conducting randomization which is commendable. However, I would like to draw the attention of the authors to following points. The term controlled (as used by the authors) scientifically is reserved for randomized controlled trials (RCT). When the term controlled is used, we usually mean a study in which groups receiving the experimental treatment are compared with control groups receiving no treatment (a placebo-controlled study). Furthermore, not all randomized clinical trials are randomized controlled trials (and some of them could never be, in cases where controls would be impractical or unethical to institute). Second, the practical difficulty of conducting randomization on a sample size limits its use in case of a study like the

one conducted by the authors. Randomization in its simplest form is like tossing of a coin; therefore, the chance of being equally distributed in two groups in a small sample is rare. Basically, there are two processes involved in randomizing patients to different interventions. First is choosing a randomization procedure to generate an unpredictable sequence of allocations. This may be a simple random assignment of patients to any of the groups at equal probabilities, may be “restricted,” or may be “adaptive.” A second and more practical issue is allocation concealment, which refers to the stringent precautions taken to ensure that the group assignment of patients is not revealed prior to definitively allocating them to their respective groups. Both of these procedures are effective in generating patient distribution capable of yielding unbiased results. Nonrandom “systematic” methods of group assignment, such as alternating subjects between one group and the other, can cause “limitless contamination possibilities” and can cause a breach of allocation concealment. The authors have done a decent enough job in describing in detail the process of randomization, but an average reader would have been benefited if some details on the points as mentioned above was provided.

Sunil Kumar Raina Department of Community Medicine, Dr. Rajendra Prasad Government Medical College, Tanda, Kangra, Himachal Pradesh - 176 001, India.

Annals of Indian Academy of Neurology, October-December 2014, Vol 17, Issue 4

482

Letters to the Editor For correspondence:

Dr. Sunil Kumar Raina, Department of Community Medicine,

Dr. Rajendra Prasad Government Medical College, Tanda, Kangra, Himachal Pradesh - 176 001, India. E-mail: [email protected]

peripheral neuropathic condition. [MAINTAIN]: Results of a pilot study. Ann Indian Acad Neurol 2014;17:19-24.

Access this article online Quick Response Code:

Reference 1.

Vasudevan D, Naik MM, Mukaddam OI. Efficacy and safety of methylcobalamin, alpha lipoic acid and pregabalin combination versus pregabalin monotherapy in improving pain and nerve conduction velocity in type 2 diabetes associated impaired

Website: www.annalsofian.org

DOI: 10.4103/0972-2327.144049

Announcement

Android App A free application to browse and search the journal’s content is now available for Android based mobiles and devices. The application provides “Table of Contents” of the latest issues, which are stored on the device for future offline browsing. Internet connection is required to access the back issues and search facility. The application is compatible with all the versions of Android. The application can be downloaded from https://market.android.com/details?id=comm.app.medknow. For suggestions and comments do write back to us.

Annals of Indian Academy of Neurology, October-December 2014, Vol 17, Issue 4

Copyright of Annals of Indian Academy of Neurology is the property of Medknow Publications & Media Pvt. Ltd. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use.